These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28552907)

  • 1. A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer.
    Wang XS; Kong DJ; Lin TY; Li XC; Izumiya Y; Ding XZ; Zhang L; Hu XC; Yang JQ; Gao SG; Lam KS; Li YP
    Acta Pharmacol Sin; 2017 Jun; 38(6):931-942. PubMed ID: 28552907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microemulsion co-loaded with Schizandrin A-docetaxel enhances esophageal carcinoma treatment through overcoming multidrug resistance.
    Su X; Gao C; Shi F; Feng X; Liu L; Qu D; Wang C
    Drug Deliv; 2017 Nov; 24(1):10-19. PubMed ID: 28155336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfide cross-linked micelles of novel HDAC inhibitor thailandepsin A for the treatment of breast cancer.
    Xiao K; Li YP; Wang C; Ahmad S; Vu M; Kuma K; Cheng YQ; Lam KS
    Biomaterials; 2015 Oct; 67():183-93. PubMed ID: 26218744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma.
    Gu Z; Wang X; Cheng R; Cheng L; Zhong Z
    Acta Biomater; 2018 Oct; 80():288-295. PubMed ID: 30240956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
    Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
    J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine and γ-cyclodextrin/docetaxel inclusion complex-loaded liposome for highly effective combinational therapy of osteosarcoma.
    Sun L; Zhou DS; Zhang P; Li QH; Liu P
    Int J Pharm; 2015 Jan; 478(1):308-317. PubMed ID: 25433201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
    Liu D; Liu Z; Wang L; Zhang C; Zhang N
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of docetaxel and bortezomib based on a targeting nanoplatform for enhancing cancer chemotherapy effects.
    Nie J; Cheng W; Peng Y; Liu G; Chen Y; Wang X; Liang C; Tao W; Wei Y; Zeng X; Mei L
    Drug Deliv; 2017 Nov; 24(1):1124-1138. PubMed ID: 28789585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor Efficacy of Docetaxel-loaded Nanocarrier against Esophageal Cancer Cell Bearing Mice Model.
    Huang ZJ; Yang N; Xu TW; Lin JQ
    Drug Res (Stuttg); 2015 Aug; 65(8):403-9. PubMed ID: 25188607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
    Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT
    Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration-dependent radiosensitizing effect of docetaxel in esophageal squamous cell carcinoma cells.
    Miyanaga S; Ninomiya I; Tsukada T; Okamoto K; Harada S; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
    Int J Oncol; 2016 Feb; 48(2):517-24. PubMed ID: 26676807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective comparison of docetaxel and paclitaxel for patients with advanced or recurrent esophageal cancer who previously received platinum-based chemotherapy.
    Mizota A; Shitara K; Kondo C; Nomura M; Yokota T; Takahari D; Ura T; Muro K
    Oncology; 2011; 81(3-4):237-42. PubMed ID: 22094594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bortezomib Enhances the Antitumor Effects of Interferon-β Gene Transfer on Melanoma Cells.
    Rossi UA; Finocchiaro LME; Glikin GC
    Anticancer Agents Med Chem; 2017; 17(5):754-761. PubMed ID: 27677689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of using prodrug-modified cationic liposome nanocomplexes and a potentiating strategy via targeted co-delivery of gemcitabine and docetaxel for CD44-overexpressed triple negative breast cancer therapy.
    Fan Y; Wang Q; Lin G; Shi Y; Gu Z; Ding T
    Acta Biomater; 2017 Oct; 62():257-272. PubMed ID: 28859899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
    Hwang HY; Kim IS; Kwon IC; Kim YH
    J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.
    Jiang S; Gong X; Zhao X; Zu Y
    Drug Deliv; 2015 Feb; 22(2):206-13. PubMed ID: 24471890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy.
    Chen Z; Tai Z; Gu F; Hu C; Zhu Q; Gao S
    Eur J Pharm Biopharm; 2016 Oct; 107():130-41. PubMed ID: 27393562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
    Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
    Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma.
    Zuccari G; Milelli A; Pastorino F; Loi M; Petretto A; Parise A; Marchetti C; Minarini A; Cilli M; Emionite L; Di Paolo D; Brignole C; Piaggio F; Perri P; Tumiatti V; Pistoia V; Pagnan G; Ponzoni M
    J Control Release; 2015 Aug; 211():44-52. PubMed ID: 26031842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic enhancement of cancer therapy using a combination of ceramide and docetaxel.
    Feng LX; Li M; Liu YJ; Yang SM; Zhang N
    Int J Mol Sci; 2014 Mar; 15(3):4201-20. PubMed ID: 24619193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.